TGFB1 and neoplasm: Tumor-derived vesicles can carry immunosuppressive molecules, such as programmed death ligand 1 (PD-L1) and transforming growth factor-β (TGF-β), which inhibit immune cell activity and facilitate immune evasion by tumor cells [58,59].